The Midwest faces some of the highest obesity rates in the country, and Lee's Summit is no exception. With Missouri reporting 35.5% obesity prevalence and 11.5% diabetes, the need for effective GLP-1 treatment is urgent. Tirzepatide has shown average weight loss of 20-25% of body weight of body weight in clinical trials, and Weight Method makes it accessible to Lee's Summit residents through a fully virtual program.
GLP-1 treatment prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · Lee's Summit is already seeing results
GLP-1 weight-loss treatment available to eligible patients in Lee's Summit, MO. Weight Method offers compounded tirzepatide, prescribed by licensed providers, from $329/month with virtual consultations and direct-to-door shipping.
For many people in Lee's Summit, diet and exercise alone have not produced lasting results — and that is not a failure of willpower. Tirzepatide (Mounjaro / Zepbound) addresses the hormonal drivers of excess weight, helping your body regulate appetite at the source. Weight Method's telehealth program brings this treatment to Missouri residents with a streamlined process: complete an online assessment, consult with a licensed provider, and receive your Tirzepatide shipped directly to your Lee's Summit address. Average weight loss in clinical trials is 20-25% of body weight of body weight over 12-18 months.
In a fast-moving city like Lee's Summit, time is the scarcest resource. Tirzepatide requires just one weekly injection and periodic virtual check-ins with your Weight Method provider — no recurring clinic visits, no disruption to your routine. Your medication arrives at your Lee's Summit address, and clinical trials show 20-25% of body weight average weight loss, giving urban professionals a realistic path to results.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Consult with a licensed provider in Missouri and start Tirzepatide from $329/month.
Get Started NowFree consultation. No commitment.